Xyall
PrivateLast Round
Series C
Feb 11, 2026
Total Funding Raised
$20.87M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Xyall is a medtech company that develops and provides automated tissue dissection solutions for molecular pathology testing.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment, Precision Medicine, Workflow Automation, Industrial Robotics
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Xyall Comparables
Compare Xyall with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Roche Holding | 75% | |
| Zeiss | 71% | |
| Morphle Labs | 71% | |
Xyall Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Feb 11, 2026 | ||||
| Series B | May 24, 2022 | ||||
| Series A | Jan 13, 2020 |
Xyall Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Brabantse Ontwikkelings Maatschappij | Series B |
| Capricorn Partners | Series C |
| BOM Brabant Ventures | Series C, Series A |
| Health Investment Partners | Series C, Series B |
| Netherlands Enterprise Agency | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2026
Open roles increased to 12, 48% of headcount.
- Aug 1, 2026
Grew 19% QoQ, from 21 to 25 employees.
Xyall Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Xyall's valuation, stock price, and market status.